140 related articles for article (PubMed ID: 36936082)
1. Blood RNA alternative splicing events as diagnostic biomarkers for infectious disease.
Zhang Z; Sauerwald N; Cappuccio A; Ramos I; Nair VD; Nudelman G; Zaslavsky E; Ge Y; Gaitas A; Ren H; Brockman J; Geis J; Ramalingam N; King D; McClain MT; Woods CW; Henao R; Burke TW; Tsalik EL; Goforth CW; Lizewski RA; Lizewski SE; Weir DL; Letizia AG; Sealfon SC; Troyanskaya OG
Cell Rep Methods; 2023 Feb; 3(2):100395. PubMed ID: 36936082
[TBL] [Abstract][Full Text] [Related]
2. Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis.
Maleknia S; Tavassolifar MJ; Mottaghitalab F; Zali MR; Meyfour A
Mol Med; 2022 Aug; 28(1):86. PubMed ID: 35922752
[TBL] [Abstract][Full Text] [Related]
3. Abnormal global alternative RNA splicing in COVID-19 patients.
Wang C; Chen L; Chen Y; Jia W; Cai X; Liu Y; Ji F; Xiong P; Liang A; Liu R; Guan Y; Cheng Z; Weng Y; Wang W; Duan Y; Kuang D; Xu S; Cai H; Xia Q; Yang D; Wang MW; Yang X; Zhang J; Cheng C; Liu L; Liu Z; Liang R; Wang G; Li Z; Xia H; Xia T
PLoS Genet; 2022 Apr; 18(4):e1010137. PubMed ID: 35421082
[TBL] [Abstract][Full Text] [Related]
4. A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants.
Albright J; Mick E; Sanchez-Guerrero E; Kamm J; Mitchell A; Detweiler AM; Neff N; Tsitsiklis A; Hayakawa Serpa P; Ratnasiri K; Havlir D; Kistler A; DeRisi JL; Pisco AO; Langelier CR
mSystems; 2023 Feb; 8(1):e0067122. PubMed ID: 36507688
[TBL] [Abstract][Full Text] [Related]
5. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
[TBL] [Abstract][Full Text] [Related]
6. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Novel COVID-19 nsp8 One-Tube RT-LAMP-CRISPR Assay for SARS-CoV-2 Diagnosis.
Yip CC; Sridhar S; Chan WM; Ip JD; Chu AW; Leung KH; Cheng VC; Yuen KY; To KK
Microbiol Spectr; 2022 Dec; 10(6):e0196222. PubMed ID: 36445095
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Various Alternative Economical and High Throughput SARS-CoV-2 Testing Methods within Resource-Limited Settings.
Duma Z; Ramsuran V; Chuturgoon AA; Edward VA; Naidoo P; Mkhize-Kwitshana ZL
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430827
[TBL] [Abstract][Full Text] [Related]
9. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
Clin Infect Dis; 2022 Aug; 75(1):e1028-e1036. PubMed ID: 35022711
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
[TBL] [Abstract][Full Text] [Related]
11. Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.
Strasser EF; Steininger PA; Korn K; Achenbach S; Tenbusch M; Cunningham S; Zimmermann R; Überla K; Hackstein H
Transfusion; 2021 Feb; 61(2):368-374. PubMed ID: 33125162
[TBL] [Abstract][Full Text] [Related]
12. Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Dalai SC; Dines JN; Snyder TM; Gittelman RM; Eerkes T; Vaney P; Howard S; Akers K; Skewis L; Monteforte A; Witte PR; Wolf C; Nesse H; Herndon M; Qadeer J; Duffy S; Svejnoha E; Taromino C; Kaplan IM; Alsobrook J; Manley T; Baldo L
Clin Infect Dis; 2022 Dec; 75(12):2079-2087. PubMed ID: 35521791
[TBL] [Abstract][Full Text] [Related]
13. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations.
Ptasinska A; Whalley C; Bosworth A; Poxon C; Bryer C; Machin N; Grippon S; Wise EL; Armson B; Howson ELA; Goring A; Snell G; Forster J; Mattocks C; Frampton S; Anderson R; Cleary D; Parker J; Boukas K; Graham N; Cellura D; Garratt E; Skilton R; Sheldon H; Collins A; Ahmad N; Friar S; Burns D; Williams T; Godfrey KM; Deans Z; Douglas A; Hill S; Kidd M; Porter D; Kidd SP; Cortes NJ; Fowler V; Williams T; Richter A; Beggs AD
Clin Microbiol Infect; 2021 Sep; 27(9):1348.e1-1348.e7. PubMed ID: 33901668
[TBL] [Abstract][Full Text] [Related]
15. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
[TBL] [Abstract][Full Text] [Related]
16. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
[TBL] [Abstract][Full Text] [Related]
17. Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay.
Ippoliti C; De Maio F; Santarelli G; Marchetti S; Vella A; Santangelo R; Sanguinetti M; Posteraro B
Microbiol Spectr; 2022 Aug; 10(4):e0099022. PubMed ID: 35863025
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic devices for detection of RNA viruses.
Basiri A; Heidari A; Nadi MF; Fallahy MTP; Nezamabadi SS; Sedighi M; Saghazadeh A; Rezaei N
Rev Med Virol; 2021 Jan; 31(1):1-11. PubMed ID: 32844526
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19.
An S; Li Y; Lin Y; Chu J; Su J; Chen Q; Wang H; Pan P; Zheng R; Li J; Jiang J; Ye L; Liang H
Front Immunol; 2021; 12():756288. PubMed ID: 34777369
[TBL] [Abstract][Full Text] [Related]
20. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
